TheJobsMapFibroBiologics (Nasdaq: FBLG) jobs and careers
United States
About FibroBiologics (Nasdaq: FBLG)
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Founded in 2021 by Pete O'Heeron.
- Founded
- 2021
- Employees
- 11 to 50
- Total funding
- $105M
- Headquarters
- United States
Leadership
The top of FibroBiologics (Nasdaq: FBLG)'s org chart, with how many people report into each leader.
Pete O'Heeron
Chairman/CEO/Founder
Jobs at FibroBiologics (Nasdaq: FBLG)
No open positions right now. Explore more companies on TheJobsMap.